Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals

Hepatitis C virus (HCV) eradication by antivirals promote fibrosis modification. Whether host genetics determined fibrosis regression in chronic hepatitis C (CHC) patients with sustained virological response (SVR) is to be determined. One hundred and fifty-six SVR patients with paired liver biopsy b...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chung-Feng, Yeh, Ming-Lun, Huang, Ching-I, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Chen, Jyh-Jou, Yu, Ming-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180045/
https://www.ncbi.nlm.nih.gov/pubmed/30305682
http://dx.doi.org/10.1038/s41598-018-33448-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180045/
https://www.ncbi.nlm.nih.gov/pubmed/30305682
http://dx.doi.org/10.1038/s41598-018-33448-1

Ejemplares similares